Novel potent inhibitor of feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies

Novel Inhibitor of Hepatitis C Viral Infectivity

Novel oral prodrug of GS-441524, inhibiting SARS-CoV-2, including variants of concern (VOC) in cell culture and human airway epithelium organoids

Potent and selective inhibitor of HIV-1 protease, effectively inhibiting protease mutants with amino acid insertions, also inhibiting major aspartyl peptidase 1 (May1), a secreted Cryptococcus neoformans protease

Novel high potent and selective stabilizer of the MYC G-quadruplex (G4)

Glutamate receptor antagonist and radical scavenging agent

Novel allosteric HIV-1 integrase (IN) inhibitor, disrupting formation of mature HIV particles

Novel potent EchA6 inhibitor

Potent inhibitor of AKT kinase

Novel dual H1 and H3 receptor antagonist with a long duration of action

Potent inhibitor of AKT kinase, showing activity against auxotrophic M. tuberculosis and being potentiated with meropenem

Novel inhibitor of polo-like kinase

Novel inhibitor of polo-like kinase

Potent and selective GPR119 agonist

Novel selective inhibitor of MmpL3 mutation

Novel allosteric inhibitor of human immunodeficiency virus (HIV) integrase, blocking viral replication and abnormal multimerization involving specific protein domains

Non-peptidic snail toxin; Activator of the Kv1.1 potassium ion channel

Novel specific P2X(7) receptor antagonist

Novel dual inhibitor of BPTF and Brd4

Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv

Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv

Novel noncompetitive inhibitor of rTbIPMK